Table 2.
Characteristics of included preclinical studies for meta-analysis.
| Author's name | Country | Year | Animal Model | Sex | Human/Animal | Exosome source | Passage number | Characterization | Isolation method | Exosome size | Exosome marker | Endosomal origin markers | Induced method | Concentration | Exosome admin. | End point | Outcome | Ref. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wang H et al. | USA | 2019 | C57BL/6 mice | N/A | Animal | Primary mouse satellite cells | P2 | NTA | Centrifugation + Filtration | 91 ± 1.9 nm | Tsg101 | I.M. | N/A | 3rd day | 14 days after injection | Exo/miR29 improves skeletal muscle atrophy and reduces kidney fibrosis by suppressing YY1 and TGF-b pathway proteins. | [49] | |
| Liu X et al. | USA | 2019 | C57BL/6 mice | Male | Human | HKC-8 | N/A | TEM | Ultracentrifugation | 30–100 nm | CD63 | TSG101 | I.V. | 20 mg/kg | 1st day | 11th day after injection | Tubule-derived exosomes contribute to renal fibrogenesis by transporting Sonic Hedgehog (Shh) ligand. | [45] |
| Liu B et al. | China | 2020 | SD rats | Male | Human | hUCMSCs | P3 | TEM | Centrifugation + Filtration | 50–100 nm | CD9, CD63 & CD81 | NA | I.C. | 200 μg | N.A. | 14th day after injection. | HucMSC-Ex attenuated UUO-induced renal fibrosis and tubular cell apoptosis by inhibiting the ROS-mediated p38MAPK/ERK signaling pathway. | [44] |
| Wang Y et al. | China | 2020 | Bred Fisher rats | N/A | Animal | BM-MSCs | P2 | N/A | Centrifugation + Filtration | N/A | CD44, CD29 | Alpha 4-integrin | I.V. | N/A | 0 day | 14th day after injection. | MiR-294/miR-133 overexpression prevented TGF-β1-induced epithelial-mesenchymal transition in HK2 cells by inhibiting SMAD2/3 and ERK1/2 phosphorylation. | [24] |
| Zhao M et al. | China | 2021 | SD Rats | N/A | Animal | Rat urine sample | N/A | TEM, NTA | Ultracentrifugation | 30–150 nm | CD63, CD81 | NA | I.V. | 12.50 g/kg | N.A. | 18weeks after injection | MHCD mitigated renal fibrosis in IgA nephropathy rats by suppressing the TGF-β1/Smad3 pathway through exosomal downregulation of TGF-β1 expression. | [39] |
| Jin J et al. | China | 2021 | C57BL/6 mice | Female | Human | BM-MSCs | N/A | TEM, NTA | Exosome Isolation Kit | 50–150 nm | CD 9, CD 81 | NA | I.V. | 50 μg | Twice a week | 28th day | MSC exosomal anti-let-7i-5p combats TGF-β1-induced fibrosis in NRK52E cells and UUO-induced renal fibrosis in vivo. | [47] |
| Liu L et al. | China | 2021 | C57BL/6 mice | Male | Human | PSC-MSCs | P3∼8 | NTA | Centrifugation + Filtration | 10∼150 nm | CD90, CD45, CD105 & CD19 | NA | I.V. | 1 × 1011 (Particle amount) | N.A. | 14th day after injection. | Upregulating SIRT6 expression while downregulating β-catenin and its downstream products. | [48] |
| Liu L et al. | S. Korea | 2021 | BALB/c mice | Male | Human | AD-MSC | P2 | TEM, NTA | Exosome isolation kit | 173.02 ± 2.34 nm | CD81 & CD9 | NA | I.V. | 100 μg | twice a week for 2 weeks | 3rd week after administration | Exocue treatment downregulated CKD-related miRNAs, improving kidney function via aquaporin upregulation and reduced urea and creatinine levels. | [41] |
| Liu Y et al. | China | 2022 | SD rats | Male | Human | BM-MSCs | P4∼6 | TEM, NTA | Centrifugation + Filtration | 30–150 nm | CD9, CD63, & CD81 | NA | I.V. | 150 μg/week | Once a week | 16th week | BMSC-Exo strengthened si-Smurf2's protective effect against TGF-β1-induced fibrosis. | [36] |
| Zheng H et al. | China | 2022 | C57BL/6 mice | Male | Human | 293 cell line human embryonic kidney cells | N/A | TEM | Ultracentrifugation | 100 nm | CD63, CD81 | NA | I.V. | 100 μg | Once a week | 28th day | Exo-miR-26a relieved kidney-downregulated miR-26a expression, tubular injury, and aldosterone (ALD)-induced TIF. | [40] |
| Alasmari W et al. | Saudi Arabia | 2022 | Albino rats | Female | Animal | BM-MSCs | P3 | TEM | Centrifugation + Filtration | 70 nm | CD63, CD81 | NA | I.V. | 100 μg | 24 h after ovariectomy | 8th week | Exosomes hinder CKD progression by lowering gene expression of NGAL, TGF-β1, and α-SMA. | [37] |
| Liang M et al. | China | 2022 | C57BL/6 mice | N/A | Human | HK-2 cells proximal tubular cell line | N/A | TEM, NTA | Centrifugation + Filtration | 100–150 nm | CD63 | TSG101 | I.V. | N/A | twice weekly for 4 weeks |
28th day | MiR-374a-5p hinders renal fibrosis progression by modulating the MAPK6/MK5/YAP axis. | [38] |
| Lu Y et al. | China | 2023 | BALB/c mice | Male | Animal | Mouse renal tubular cell line TCMK-1 | N/A | TEM | Ultracentrifugation | 145.8 nm | HSP70, CD63 | TSG101 | I.V. | 100 μg | Per day for 5 days | 7th day | TGF-β-induced TECs co-cultured with macrophages led to M1 polarization. Exosomes from TECs without TGF-β or with TGF-β alone did not induce M1 macrophage markers. | [34] |
| Wang Z et al. | China | 2023 | C57BL/6 mice | Male | Human | hucMSCs | N/A | TEM, NTA | Ultracentrifugation | 30–150 nm | CD63, | Tsg101, & Alix | I.V. | 100 μg | Once 7 days after surgery | 14th day | Inhibited expression of proteins related to the Wnt/β-catenin signaling pathway. | [35] |
| Y. Wan et al. | China | 2023 | SD Rats | Male | Human | hucMSCs | P5 | TEM, NTA | Ultracentrifugation | 30–150 nm | CD63 | Tsg101, & Alix | I.V. | 250 μg | Immediately after reperfusion | 24 h after injection | HucMSC-Ex reduced pyroptosis-related proteins (NLRP3, GSDMD, caspase-1, and IL-1β) in renal tissue of IRI rats. | [46] |
| Xi Liu et al. | China | 2023 | C57BL/6 mice | Male | Human | HKC-8 | N/A | TEM, NTA | Ultracentrifugation | 30–150 nm | CD63 | Tsg101 | I.V. | 200 μg | Once in 2 days | 14th day | Exo-TNFAIP8 promotes fibroblast survival by inducing p53 degradation and stimulating proliferation. | [43] |
| Di Yin et al. | China | 2023 | C57BL/6 mice | Male | Animal | Tubular epithelial cells of mouse | N/A | TEM, NTA | Ultracentrifugation | 129.5 ± 8.2 nm | CD63, CD9 | Tsg101, & Alix | I.P. | 200 μg | Once on day 1 | 3rd day | Quercetin inhibits exosome release, exerting renoprotective effects by suppressing Hsp70 or Hsp90. | [42] |
Abbreviations: N/A: not applicable; I.V.: intravenous; IM: Intramuscular; I.C: Intracellular; IP: Intraparietal; HKC-8:Human proximal tubular epithelial cells; HbMSCs: Human bone marrow derived; hucMSCs: Human umbilical cord mesenchymal stem cells; AD: Human adipose; PSC-MSCs: pluripotent stem cell-derived mesenchymal stem cells.